To cater to new niche segments and sharpen its focus among customers, Torrent Pharma has six marketing divisions, each catering to defined therapeutic segment. A 2300 strong field force caters to around 2,00,000 doctors across the country, which makes it rank fifth in terms of market reach.

Torrent Pharma's competitive advantage as a manufacturer stems from its world-class manufacturing facilities. Its manufacturing facilities at Indrad, Gujarat. With a view to cater to its growth requirements, Torrent Pharma commissioned a new formulations manufacturing facility at Baddi, Himachal Pradesh, in November 2005. The facility has a capacity to manufacture 3600 million tablets, 400 million capsules and 18 million Oral Liquid bottles, per annum and would cater to the domestic formulations requirement.

Torrent has a modern and well-equipped state-of-the-art R&D Centre, built with an investment of US $ 40 million. It is manned by more than 525 highly qualified scientists, with a combined experience of over 2500 scientific man-years in Drug Discovery and Development. Torrent Pharma has earmarked 9% of sales year-after-year for R&D advancement.

In the International operations arena, Torrent Pharma exports to more than 50 countries around the world with over 1000 product registrations. The international business has been broadly divided into five zones- USA, Latin America, Russia and CIS, Western Europe and CEE and Rest of the World (ROW). For its export excellence in International Business, Torrent Pharma has won several prestigious export awards.